Market Place
Reply
1. Nilotinib (150 mg) Capsules. The required quantity is 44,800 units for 1st year, 67,200 units for 2nd year & 89,600 units for 3rd year.
2. Nilotinib (200 mg) Capsules. The required quantity is 5,600 units for 1st year, 11,200 units for 2nd year and 16,800 units for 3rd year.
Comments :
info@indeximinternational.com
INDEXIM INTERNATIONAL, one of the leading manufacturer, suppliers, exporter and importer of API, Pharmaceutical formulation, Novel molecule, APIs, Vet.-APIs, reference standard, Impurities, Excipients, Intermediates, Solvents, Vitamins, Nutraceuticals and Dietary supplements, silica gel, Regulatory documents service etc.
We are exporting several of our products to Latin American countries, Gulf & Asian, Ukraine, Russia, and also a few products to Australia, UK & USA.
We are also contract manufacturer of APIs and attached is the list of products and by cooperation with other manufacturers in India. Also, most of the products are from WHO cGMP, ISO, GMP manufacturers.
sales.indeximinternational@gmail.com
info@indeximinternational.com
www.indexim.in
GSTN-24AADFI5767R1ZO
IEC -CODE : 0811024407
FDA No- 20B-168327/21B-168328
ISO 9000 AND GMP APPROVED
chowdary@carbontree.in
Dear Sir,
We have EUGMP, UKMHRA, PIC/s, WHOGMP, Belarus, Russia, Korean GMP exclusive oncology fdf facility in Hyderabad, India. We have been registered 140 products in EU, LATAM and other countries.
Nilotinib 150mg & 200mg already producing in our facility and able to support for in-licensing. Please feel free to contact for further discussion.
Please visit our website for more information
PA Chowdary
bd@spaccurelabs.com
www.spaccurelabs.com
www.tizig.com
vishvesh.shaishav@gmail.com
We are focussed on developing new manufacturing technologies, including custom synthesis of new moleculepharma intermediate, catalyst, bulk drugs, pharma API, pharma chemicals, active pharmaceutical ingredients, pharmaceutical pellets,additives, contract manufacturing, chemicals. We began in the field of specialty intermediates for pharmaceutical applications and developed our own purification technologies for manufacturing highly pure intermediates. And Pharmaceutical API At a later stage, we integrated forward to manufacture finished formulations for both veterinary and human consumption. Due to our completely integrated operations in the pharmaceutical sector, we continuously learn about the quality parameters for an API based on the performance of the finished formulation in order to quality their Bioequivalence Studies.
We have established finished formulation lines in South Asian and Latin American countries. It is our vision to achieve worldwide recognition as an excellent business partner from India by providing our customers with superior quality products at highly affordable prices and following that up with reliable service consistently, thereby giving them an unparalleled experience.
Our focus lies in developing new production technologies with a keen interest in frugal innovation in order to gain a competitive edge over others. We specialize in the custom synthesis of molecules and work with many reputed companies around the world on an OEM basis.pharmaceutical pellets,Intermidiates
Our finished formulations from WHO-GMP and EU-GMP units are registered/being registered in 26 countries within Asia, Europe, North America, Latin America and Africa continents including Peru, Panama, Ecuador, Chile, Curaçao, Suriname, Haiti, Aruba, Trinidad, Tobago, Philippines, Myanmar, Laos, Malaysia, Thailand, Indonesia, Hong Kong, Vietnam, Sri Lanka, Maldives, Brunei, Nepal, China, Russia, Croatia, Venezuela and Bhutan.
vishvesh.shaishav@gmail.com
info@eqpharma.com
we can support you
info@eqpharma.com
we can support you
namrata.sutphinrx@gmail.com
Sutphin Drugs Inc are licensed distributors of USFDA approved Reference Listed Drugs (RLD’s) ,Branded & Generic & Comparator Drug Products.
Kindly contact at info@sutphinrld.com or namrata.sutphinrx@gmail.com
